The particular effects of BPC 157 on the maintenance of the NO systems function [49] resulted in the BPC 157 therapy promptly reversing already established doxorubicin chronic heart failure [121]
Safety and Medical Considerations Tirzepatide should always be used under medical supervision
IL-33/ST2 axis modulates the polarization and efferocytosis of decidual macrophages (dMs) [60], lead to pregnancy failure [61].Macrophage-derived IL-33 also upregulates SLC7A11 in ectopic endometrial stromal cells and protects against ferroptosis in eESC, accelerating the progression of endometriosis [62]
Ancient Egyptian texts including the Edwin Smith Papyrus mention the use of heat therapy for tumors
They need to rule out other causes for your symptoms and ensure that GLP-1 therapy is safe for your specific medical history
Back in 2018, most of its earnings came from generics, with only a small share driven by innovation. Between 2025 and 2027, the company expects to bring dozens of major breakthroughs to market from GLP-1 therapies for obesity and diabetes to next-generation oncology treatments. Source: *Opinions are my own To view or add a comment, sign in Big Pharma News: Pfizer is set to acquire Metsera in a deal worth up to $4.9B Why it matters: $47.50/share upfront + $22.50/share tied to milestones Lead candidate MET-097i (GLP-1 therapy) showed 11.3% weight loss in 12 weeks Pipeline includes monthly amylin-based injections + oral obesity drugs Puts Pfizer head-to-head with Lilly & Novo Nordisk in the obesity race This move highlights the booming obesity drug market and pharmas growing appetite for metabolic innovation
